This is the first report on the role of BLT1/2 in the regulation of NLRP3 stimulation and IL-1β synthesis in a neutrophilic airway inflammation mouse model, and our results may provide a perspective for the development of treatments for asthma patients with steroid resistance. The gene discussed is NLRP3; the disease is inflammation.